Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

January
26
2018

How to Perform a Skin Cancer Self-Exam

According to the Skin Cancer Foundation, adults should thoroughly examine their skin on a monthly basis for signs of skin cancer, as well as visit a dermatologist for an annual professional skin exam. If you’ve…

January
25
2018

Sensus Healthcare to Host Fourth Quarter and Fiscal Year 2017 Financial Results and Business Update Conference Call on February 1, 2018

BOCA RATON, Fla., Jan. 25, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that management…

January
23
2018

Global Keloid Treatment Market to Reach US $4.4 Billion by 2027

The expected increase of keloid scar occurrences, the shift from Mohs surgery as well as developments in advanced cryosurgery and radiation therapy devices will bring about an increase in the demand for keloid treatment. Read…

December
28
2017

Offer Skin Cancer Treatment Without Surgery

Treating Non-Melanoma Skin Cancers When a person discovers they have non-melanoma skin cancer such as basal cell carcinoma or squamous cell carcinoma, the first question they have is, “How can I treat this?” The current…

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy